Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment

American Heart Journal

Volumn 165, Issue 6, 2013, Pages 862-868

  Al Khatib, Sana M ^a,i   Fonarow, Gregg C ^b   Hayes, David L ^c   Curtis, Anne B ^d   Sears, Samuel F ^e   Sanders, Gillian D ^a   Hernandez, Adrian F ^a   Mirro, Michael J ^f   Thomas, Kevin L ^a   Eapen, Zubin J ^a   Russo, Andrea M ^g   Yancy, Clyde W ^h  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

^f Parkview Health System   (United States)

^g Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; CARDIOVASCULAR RISK; EVIDENCE BASED PRACTICE; HEALTH CARE QUALITY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; OUTCOME ASSESSMENT; PERFORMANCE MEASUREMENT SYSTEM; PRIMARY PREVENTION; PRIORITY JOURNAL; RESUSCITATION; SECONDARY PREVENTION; SUDDEN CARDIAC DEATH; TOTAL QUALITY MANAGEMENT;

EID: 84880048074     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.02.010     Document Type: Review

References (45)

1. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98: 2334-51.
2. Gilman JK, Jalal S, Naccarelli GV. Predicting and preventing sudden death from cardiac causes. Circulation 1994;90:1083-92.
3. Kong MH, Fonarow GC, Peterson ED, et al. Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol 2011;57:794-801.
4. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012;125;e2-220.
5. Sasson C, Keirns CC, Smith DM, et al. Examining the contextual effects of neighborhood on out-of-hospital cardiac arrest and the provision of bystander cardiopulmonary resuscitation. Resuscitation 2011;82:674-9.
6. Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008; 300:1423-31.
7. McNally B, Robb R, Mehta M, et al. Out-of-hospital cardiac arrest surveillance-Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005-December 31, 2011. Centers for Disease Control and Prevention, Morbidity and Mortality weekly report. July 29, 2011;60:1-19. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss6008a1.htm. Accessed March 1, 2012.
8. Vadeboncoeur TF, Richman PB, Darkoh M, et al. Bystander cardiopulmonary resuscitation for out-of-hospital cardiac arrest in the Hispanic vs the non-Hispanic populations. Am J Emerg Med 2008; 26:655-60.
9. O'Connor RE, McGinnis-Hainsworth D, Megargel RE, et al. Racial disparities in the rate of bystander CPR.Circulation 2006;114:II-553-4.
10. Albert NM, Yancy CW, Liang L, et al. Use of aldosterone antagonists in heart failure. JAMA 2009;302:1658-65.
11. Fonarow GC, Yancy CW, Albert NM, et al. Heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF. Circ Heart Fail 2008;1:98-106.
12. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90.
13. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
14. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8.
15. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
16. Epstein AE, DiMarco JP, Ellenboge KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 2008;117:e350-408.
17. Thomas KL, Al-Khatib SM, Kelsey II RC, et al. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of b or = 35%. Am J Cardiol 2007;100:924-9.
18. Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 2007;298: 1525-32.
19. Curtis LH, Al-Khatib SM, Shea AM, et al. Sex differences in the use of implantable cardioverter defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 2007;298:1517-24.
20. Eapen ZJ, Peterson ED, Fonarow GC, et al. Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice. Am Heart J 2011;162:222-31.
21. Report to Congress: National Strategy for Quality Improvement in Health Care. HealthCare.gov Web site. http://www.healthcare.gov/center/reports/ quality03212011a.html. Accessed March 1, 2012.
22. Chassin MR, Loeb JM, Schmaltz SP, et al. Accountability measures-using measurement to promote quality improvement. N Engl J Med 2010;363:683-8.
23. NQF-endorsed standards. National Quality Forum Web site. http://www.qualityforum.org/Measures-List.aspx Accessed March 1, 2012.
24. Measuring Performance. National Quality Forum Web site. http://www.qualityforum.org/Measuring-Performance/Measuring-Performance.aspx Accessed March 1, 2012.
25. Cohen MG, Fonarow GC, Peterson ED, et al. Racial and ethnic differences in the treatment of acute myocardial infarction: Findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation 2010;121:2294-301.
26. Schwamm LH, ReevesMJ, PanW, et al. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation 2010;121:1492-501.
27. Fonarow GC, Albert NM, Curtis AB, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: Primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE-HF). Circulation 2010;122:585-96.
28. Walsh MN, Yancy CW, Albert NM, et al. Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: Findings from IMPROVE-HF. J Card Fail 2010;16: 940-9.
29. Fonarow GC, Albert NM, Curtis AB, et al. Associations between outpatient heart failure process-of-care measures and mortality. Circulation 2011;123:1601-10.
30. National Quality Forum Web site. http://www.qualityforum.org Accessed March 1, 2012.
31. NQF Endorses Cardiovascular Measures. National Quality Forum Web site. http://www.qualityforum.org/News-And-Resources/Press-Releases/2012/ NQF-Endorses-Cardiovascular-Measures. aspx Accessed March 1, 2012.
32. Hammill SC, Kremers MS, Stevenson LW, et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010;7:1340-5.
33. American College of Cardiology Foundation (ACCF), American Heart Association (AHA), Physician Consortium for Performance Improvement (PCPI). Heart Failure: Performance Measurement Set. http://www.ama-assn.org/ama1/pub/ upload/mm/pcpi/hfset-12-5.pdf Accessed March 1, 2012.
34. The Joint Commission Technical Advisory Panel to Identify of Maintain Performance Measures for Sudden Cardiac Arrest. http://www. jointcommission.org/ assets/1/18/Web%20Page%20TAP%20PDF. pdf Accessed March 1, 2012.
35. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
36. Pitt B, RemmeW, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-21.
37. Field JM, Hazinski MF, Sayre MR, et al. Part 1: Executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010;122(18 Suppl 3):S640-56.
38. Page RL, Joglar JA, Kowal RC, et al. Automated external defibrillator use aboard a domestic airline. N Engl J Med 2000; 343:1210-6.
39. Herlitz J, Engdahl J, Svensson L, et al. Factors associated with an increased chance of survival among patients suffering from an out-ofhospital cardiac arrest in a national perspective in Sweden. Am Heart J 2005;149:61-6.
40. Sasson C, Rogers MA, Dahl J, et al. Predictors of survival from out-ofhospital cardiac arrest: A systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2010;3:63-81.
41. The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-56.
42. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-63.
43. Morrison LJ, Nichol G, Rea TD, et al. Rationale, development and implementation of the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest. Resuscitation 2008;78:161-9.
44. Get With the Guidelines (Formerly NRCPR). Resuscitation Central Web site. http://www.resuscitationcentral.com/documentation/nrcpr-cardiopulmonary- resuscitation-cpr/Accessed April 20, 2012.
45. Fonarow GC, Yancy CW, Hernandez AF, et al. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J 2011;161:1024-30.